Literature DB >> 32905648

Mitochondrial dysfunction and endoplasmic reticulum stress in the promotion of fibrosis in obstructive nephropathy induced by unilateral ureteral obstruction.

Elena Martínez-Klimova1, Omar Emiliano Aparicio-Trejo1, Tania Gómez-Sierra1, Alexis Paulina Jiménez-Uribe1, Belen Bellido1, José Pedraza-Chaverri1.   

Abstract

Obstructive nephropathy favors the progression to chronic kidney disease (CKD), a severe health problem worldwide. The unilateral ureteral obstruction (UUO) model is used to study the development of fibrosis. Impairment of renal mitochondria plays a crucial role in several types of CKD and has been strongly related to fibrosis onset. Nevertheless, in the UUO model, the impairment of mitochondria, their relationship with endoplasmic reticulum (ER) stress induction and the participation of both to induce the fibrotic process remain unclear. In this review, we summarize the current information about mitochondrial bioenergetics, redox dynamics, mitochondrial mass, and biogenesis alterations, as well as the relationship of these mitochondrial alterations with ER stress and their participation in fibrotic processes in UUO models. Early after obstruction, there is metabolic reprogramming related to mitochondrial fatty acid β-oxidation impairment, triggering lipid deposition, oxidative stress, (calcium) Ca2+ dysregulation, and a reduction in mitochondrial mass and biogenesis. Mitochondria and the ER establish a pathological feedback loop that promotes the impairment of both organelles by ER stress pathways and Ca2+ levels dysregulation. Preserving mitochondrial and ER function can prevent or at least delay the fibrotic process and loss of renal function. However, deeper understanding is still necessary for future clinically-useful therapies.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  mitochondrial dysfunction; obstructive nephropathy; renal fibrosis; unilateral ureteral obstruction (UUO)

Mesh:

Year:  2020        PMID: 32905648     DOI: 10.1002/biof.1673

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  18 in total

1.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

Review 2.  Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases.

Authors:  Ana Karina Aranda-Rivera; Alfredo Cruz-Gregorio; Omar Emiliano Aparicio-Trejo; José Pedraza-Chaverri
Journal:  Biomolecules       Date:  2021-08-03

3.  Mitoquinone Protects Podocytes from Angiotensin II-Induced Mitochondrial Dysfunction and Injury via the Keap1-Nrf2 Signaling Pathway.

Authors:  Zijing Zhu; Wei Liang; Zhaowei Chen; Jijia Hu; Jun Feng; Yun Cao; Yiqiong Ma; Guohua Ding
Journal:  Oxid Med Cell Longev       Date:  2021-08-13       Impact factor: 6.543

Review 4.  Extracellular Vesicles in Redox Signaling and Metabolic Regulation in Chronic Kidney Disease.

Authors:  Omar Emiliano Aparicio-Trejo; Ana Karina Aranda-Rivera; Horacio Osorio-Alonso; Elena Martínez-Klimova; Laura Gabriela Sánchez-Lozada; José Pedraza-Chaverri; Edilia Tapia
Journal:  Antioxidants (Basel)       Date:  2022-02-11

5.  Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis.

Authors:  Yu Zhang; Ping Wen; Jing Luo; Hao Ding; Hongdi Cao; Weichun He; Ke Zen; Yang Zhou; Junwei Yang; Lei Jiang
Journal:  Cell Death Dis       Date:  2021-09-13       Impact factor: 8.469

Review 6.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

Review 7.  Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment.

Authors:  Xiao-Yang Tan; Hao-Yue Jing; Yue-Rong Ma
Journal:  Front Physiol       Date:  2022-01-03       Impact factor: 4.566

8.  Mitochondrial Bioenergetic and Proteomic Phenotyping Reveals Organ-Specific Consequences of Chronic Kidney Disease in Mice.

Authors:  Trace Thome; Madeline D Coleman; Terence E Ryan
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

Review 9.  Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.

Authors:  Simeng Liu; Yanggang Yuan; Yi Xue; Changying Xing; Bo Zhang
Journal:  Front Cell Dev Biol       Date:  2022-03-07

10.  Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model.

Authors:  August Hoel; Tarig Osman; Fredrik Hoel; Hassan Elsaid; Tony Chen; Lea Landolt; Janka Babickova; Karl Johan Tronstad; James B Lorens; Gro Gausdal; Hans-Peter Marti; Jessica Furriol
Journal:  J Cell Mol Med       Date:  2021-07-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.